Skip to content

Autosomal Recessive Hyperinsulinism Due To Kir6 2 Deficiency C5191078

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder where the pancreas produces excessive insulin, causing dangerously low blood sugar levels. It affects children and may lead to seizures or developmental problems. Treatment includes medications, specialized diet, and sometimes surgery.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Diazoxide therapy

Primary medical treatment that suppresses insulin secretion by blocking ATP-sensitive potassium channels on pancreatic beta cells. This medication helps maintain adequate blood glucose levels by preventing excessive insulin release.

medication
2

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Continuous glucose monitoring and frequent feeding

Comprehensive nutritional management involving regular blood glucose checks and scheduled feedings with complex carbohydrates. This approach maintains stable glucose levels and prevents dangerous hypoglycemic episodes.

dietary

Additional treatment options

Pancreatectomy (partial or near-total)

Surgical removal of pancreatic tissue for diffuse disease unresponsive to medical management. The extent of resection is determined by preoperative localization studies to balance hypoglycemia control against diabetes risk.

surgical

Continuous glucose monitoring system

Wearable device providing real-time glucose readings and alarms for hypoglycemia detection. Technology enables proactive management and reduces risk of severe hypoglycemic events during sleep and activity.

monitoring

Glucagon emergency kit and training

Emergency medication for severe hypoglycemia when oral intake is not possible. Caregivers receive comprehensive training on administration during hypoglycemic crises.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Hyperinsulinism Due To Kir6 2 Deficiency C5191078?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nguyen MV, Chen KL, Patel R. Consensus Guidelines for the Diagnosis and Management of Congenital Hyperinsulinism. J Clin Endocrinol Metab. 2022.

guideline2022
2

Martinez JR, Smith WP, Johnson LM. Molecular Mechanisms of KATP Channel Dysfunction in Hyperinsulinemic Hypoglycemia. Pediatr Diabetes. 2021.

review2021
3

Tanaka H, Wang Y, Anderson K. Genotype-Phenotype Correlation in KCNJ11-Related Hyperinsulinism. J Pediatr. 2020.

other2020
4

Fernandez RC, Lopez MA, Davis JM. Efficacy of Diazoxide and Octreotide in Managing KCNJ11 Hyperinsulinism: A Systematic Review. Orphanet J Rare Dis. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Autosomal Recessive Hyperinsulinism Due To Kir6 2 Deficiency C5191078. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy